Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke

NCT04950920 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

914

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Y-2 sublingual tablets
DRUG: d-borneol

Sponsor

Peking University Third Hospital